China news from FiercePharma
NewsPharma's new favorite outsourcing spot: China
Quality-control fears notwithstanding, China has knocked India off the catbird seat as pharma's favorite spot for outsourcing. According to a new report from PriceWaterhouse Coopers, China beats... Read more...
Olympics spawned API shortages
Like some drugs, the Beijing Olympics has had adverse side effects. As you know, China shut down an entire swath of industry to clear the air over Beijing for the games. Among the shutdowns were... Read more...
Big pharma in big China
While many are jumping on the China bandwagon for less expensive manufacturing and research and development, the country is also developing low-cost medicines that seriously undercut U.S. prices and... Read more...
Schering-Plough buys China partners
Although the company is staying tight-lipped on the details of the deals, here's a mouthful: Schering-Plough announced yesterday that it purchased Shanghai Pharmaceutical Industry and Shanghai... Read more...
Chinese pharma leapfrogs ahead
As if to bolster Big Pharma's recent turn toward emerging markets for growth, a new study has pegged China as the fifth... Read more...
Bayer eyes 20% annual growth in China
Like its Big Pharma brethren, Bayer is casting a gimlet eye on the drug market in China. The company says it's aiming for 20 percent-plus annual growth in China for each of the next five years. Most... Read more...
Microbix teams with China on vaccine plant
More evidence that Asia is the place to be these days: Canada's Microbix Biosystems is plotting a $200 million flu vaccine plant in Hunan province. The cooperative deal puts Microbix in partnership... Read more...
AZ's expanded China focus pays off
Big Pharma has been talking a lot lately about pushing into emerging markets, seeing as that's where the biggest growth prospects lie. But how, exactly, does a drugmaker go about doing that? The Wall... Read more...
Six die after Chinese antibody injections
Just as the heparin hoopla was starting to settle down, now China is reporting that six patients in Jiangxi province have died after... Read more...
Bureaucracy slows FDA offices in China
Easy to announce you're opening offices in China. Not so easy to actually do it--especially when you're wrestling with Chinese red tape. That's what the FDA is discovering as it struggles to
| Press ReleasesCovance Inc. (CVD), WuXi PharmaTech Co., Ltd. Abandon China Venture PlansCovance Inc. (CVD), WuXi PharmaTech Co., Ltd. Abandon China Venture Plans September 29, 2008 PRINCETON, N.J., Sept. 29 /PRNewswire-FirstCall/ -- Covance Inc. announced today that it will no longer Read more >> China Sky One Medical, Inc. Announces 26 New Drugs in Clinical TrialsHARBIN, China, Sept. 10 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Amex: CSY), a leading fully integrated pharmaceutical company Read more >> China's Hepatitis B Virus Drug Market Will Grow to $800 Million by 2012China's Hepatitis B Virus Drug Market Will Grow to $800 Million by 2012 WALTHAM, Mass., Aug. 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on Read more >> Statement by Mike Leavitt Secretary of HHS on the United States-China Meetings Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety WASHINGTON, Sept. 14 -- The following is a statement by Mike Read more >> PRESS RELEASE: AstraZeneca Enhances Clinical Research Capabilities in China With First Clinical Pharmacology Unit AstraZeneca Enhances Clinical Research Capabilities in China With First Clinical Pharmacology Unit AstraZeneca today announced a strategic partnership with Peking University 3rd Hospital to open its Read more >> |
Get more China coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
